TXNDC5 and esophageal squamous cell carcinoma: confirmed that HERG1 induces to poor prognosis in esophageal squamous cell carcinoma (ESCC) patients by promoting cell proliferation, migration, and invasion, while these effects can be reversed by altering the expression of TXNDC5 and its downstream PI3K/AKT pathway.